『Colombia's UDI Mandate: Pure Global on a New MedTech Compliance Trap』のカバーアート

Colombia's UDI Mandate: Pure Global on a New MedTech Compliance Trap

Colombia's UDI Mandate: Pure Global on a New MedTech Compliance Trap

無料で聴く

ポッドキャストの詳細を見る

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 This episode of LATAM MedTech Insights dives into a sudden and critical regulatory update from Colombia's INVIMA. Last week's clarification on Unique Device Identification (UDI) for Class IIa devices has created an immediate compliance challenge for manufacturers, requiring a new level of data management and specific submission protocols that have caught many off guard. We break down what the new guidance entails, the technical hurdles it presents, and the broader implications for MedTech companies operating in, or planning to enter, the Colombian market. We explore why this move is more than a simple labeling change and represents a significant step-up in local enforcement of global standards. A leading US-based orthopedic company, which packages multiple devices into single surgical kits, is now facing potential import blockades. Their global UDI strategy did not account for INVIMA's new demand for individual Device Identifier linking for every single Class IIa component within a kit. This case study reveals the hidden complexities and the urgent need to overhaul their data management systems to meet Colombia’s unique requirements. --- **Key Takeaways:** 1. What are the exact technical data points INVIMA now requires for UDI-DI registration linking? 2. Is your current local representative in Colombia equipped to handle these new digital submission requirements? 3. How does this UDI update affect devices that are already on the market versus new registrations? 4. What are the specific Spanish-language documentation requirements that could trip up your submission? 5. If your product is part of a kit, what is the new compliance burden you urgently need to address? 6. Could this sudden enforcement approach from INVIMA be a sign of future regulatory trends in Peru or Chile? 7. What is the real financial risk of having your products detained at Colombian customs due to non-compliance? --- At Pure Global, we specialize in navigating these complex regulatory landscapes. We offer end-to-end solutions for MedTech and IVD companies, combining local expertise with advanced AI and data tools to streamline global market access. Whether it's managing UDI compliance in Colombia or developing a regulatory strategy for over 30 markets worldwide, we act as your local representative to ensure you maintain market presence. Don't let regulatory surprises disrupt your business. Contact Pure Global at info@pureglobal.com or visit us at https://pureglobal.com/.
adbl_web_anon_alc_button_suppression_c
まだレビューはありません